- Pharmaceutical companies
- Jazz Pharmaceuticals
Jazz Pharmaceuticals
Phone: +353353.1.634.7800
E-mail: corporateaffairsmediainfo@jazzpharma.com
Web: https://www.jazzpharma.com
Type | Public company |
---|---|
Traded as |
|
Industry | Biotechnology Pharmaceutical |
Predecessor | Jazz Pharmaceuticals, Inc. (before the 2012 tax inversion to Ireland) |
Founded | March 2005 (2005-03) in California, U.S. |
Headquarters | Waterloo Exchange, Waterloo Road, D04 E5W7, Dublin, Ireland |
Area served | Worldwide |
Key people | Bruce C. Cozadd (Chairman & CEO) |
Products | Pharmaceutical drugs |
Brands |
|
Revenue | US$1.618 billion (2017) |
Operating income | US$528.8 million (2017) |
Net income | US$487.8 million (2017) |
Total assets | US$5.123 billion (2017) |
Total equity | US$2.713 billion (2017) |
Number of employees | ~1,210 (February 2018) |
Website | jazzpharma.com |
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients. We are focused on developing life-changing medicines for people with serious diseases — often with limited or no options — so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Through continued investment in an evolving and growing research and development focus, we seek solutions for rare or complex diseases, and ensure those solutions are available for the often-overlooked patients who need them. Our approach has allowed us to shepherd new medicines to market – from late-stage discovery through clinical development and regulatory approval. All of these advancements are a reflection of our continued investment in an evolving and growing research and development focus.
For detailed contact information visit location pages below.
Jazz Pharmaceuticals's locations around the world
Clinical Trials sponsored by Jazz Pharmaceuticals
-
Jazz PharmaceuticalsReclutamientoEnfermedad neuropsiquiátrica asociada al complejo de esclerosis tuberosaEstados Unidos, Reino Unido, Polonia
-
Jazz PharmaceuticalsReclutamientoEnfermedad de Parkinson | TemblorEstados Unidos, España, Alemania, Polonia
-
Jazz PharmaceuticalsReclutamientoTumor solido | Cáncer metastásico | Cáncer avanzadoEstados Unidos
-
Jazz PharmaceuticalsReclutamientoComplejo de esclerosis tuberosa | Síndrome de Dravet | Síndrome de Lennox GastautEstados Unidos
-
Jazz PharmaceuticalsReclutamiento
-
Jazz PharmaceuticalsActivo, no reclutandoCánceres gastrointestinales que expresan HER2, incluidos el adenocarcinoma gastroesofágico, el cáncer de las vías biliares y el cáncer colorrectalEstados Unidos, Corea, república de, Chile, Canadá
-
Jazz PharmaceuticalsActivo, no reclutandoCánceres que expresan HER2Estados Unidos, Canadá, Corea, república de
-
Jazz PharmaceuticalsTerminadoTumor sólido avanzado | Tumor sólido metastásico | Cáncer urotelial | Carcinomas neuroendocrinos poco diferenciados | Recombinación Homóloga Deficiente-Positivo Neoplasias AgnósticasEstados Unidos
-
Jazz PharmaceuticalsTerminadoEspasticidad Con Esclerosis MúltipleEspaña, Estados Unidos, Reino Unido, Chequia, Polonia
-
Jazz PharmaceuticalsActivo, no reclutandoParticipantes SaludablesEstados Unidos